By Greg Mannix, VP, EMEA Business Development, LSN
The Redefining Every Stage of Investment (RESI) Conference is coming back to London on December 4th — and it’s shaping up to be bigger and better than ever. After a successful debut in 2024, RESI London returns to unite global investors, strategic partners, and early-stage innovators across biotech, medtech, diagnostics, and digital health.
In today’s challenging funding landscape, breaking out of your regional bubble to build global relationships is essential. That’s exactly what RESI delivers — a trusted international platform where meaningful connections spark real partnerships and deals.
With 54 conferences held across three continents since 2012, RESI has become a cornerstone of the global life science community, helping startups find the right investors, and investors find their next breakthrough.
This December, RESI London will welcome international Tech Hubs and Regional Organizations collaborating through startup cohorts, promotional activities, and partner initiatives.
We’re excited to welcome cohorts from:
- Ontario (Canada)
- CEIN Navarra (Spain)
- OneNucleus (UK)
And we’re grateful for the ongoing collaboration of our global partners, including:
BioPartner UK, O2h (UK), Genopole, Lyonbiopole & Eurasanté (France), Life Science Zurich BP (Switzerland), BioM & BioRN (Germany), Biocat & Asebio (Spain), BioIndustry Park (Italy), PBio (Portugal), Business Regions Gotheborg/Skane (Sweden) — and many more.
Join us in London on December 4th to connect with the global life science ecosystem and take your innovation to the next level. There is still time to pitch in the Innovator’s Pitch Challenge APPLY HERE
90 companies have documented raising $1.29 B from connections started at RESI. Read More.
| Register for RESI London | Appy to Pitch at RESI London |
Next Phase Newsletter 
Leave a comment